Letaplimab represents a unique medical method for addressing complement-mediated conditions. This antibody targets complement component C1q, a essential molecule of the complement pathway, effectively disrupt its https://karimjwyf755313.pointblog.net/letaplimab-a-innovative-medical-method-92263714